Long-Term Follow-up of Barrett's Epithelium: Medical Versus Antireflux Surgical Therapy

Journal of Gastrointestinal Surgery

Volumn 16, Issue 1, 2012, Pages 7-15

  Zaninotto, Giovanni ^a,e   Parente, Paola ^c   Salvador, Renato ^b   Farinati, Fabio ^b   Tieppo, Chiara ^b   Passuello, Nicola ^b   Zanatta, Lisa ^b   Fassan, Matteo ^c   Cavallin, Francesco ^d   Costantini, Mario ^b   Mescoli, Claudia ^b   Battaglia, Giorgio ^d   Ruol, Alberto ^b   Ancona, Ermanno ^b   Rugge, Massimo ^c  

^a SS Giovanni e Paolo Hospital   (Italy)

^b Department of Surgical and Gastroenterological Sciences   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^e Ospedale SS Giovanni e Paolo   (Italy)

Author keywords

Barrett's esophagus; Fundoplication; GERD; PPI

Indexed keywords

CDX2 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BIOPSY; COHORT ANALYSIS; COMPARATIVE STUDY; ESOPHAGEAL PH MONITORING; ESOPHAGOSCOPY; ESOPHAGUS; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HIATUS HERNIA; HUMAN; MANOMETRY; METABOLISM; METAPLASIA; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; PATHOPHYSIOLOGY; RECURRENT DISEASE; REFLUX ESOPHAGITIS; STOMACH FUNDOPLICATION; TIME;

ADULT; AGED; BARRETT ESOPHAGUS; BIOPSY; COHORT STUDIES; ESOPHAGEAL PH MONITORING; ESOPHAGITIS, PEPTIC; ESOPHAGOSCOPY; ESOPHAGUS; FOLLOW-UP STUDIES; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HERNIA, HIATAL; HOMEODOMAIN PROTEINS; HUMANS; MANOMETRY; METAPLASIA; MIDDLE AGED; PROTON PUMP INHIBITORS; RECURRENCE; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 84855346753     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-011-1739-8     Document Type: Article

References (32)

1. Falk GW. Barrett's esophagus. Gastroenterology 2002; 122: 1569-91.
2. DeMeester SR, DeMeester TR. Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg 2000; 231: 300-32.
3. Cameron AJ, Carpenter HA. Barrett's esophagus, high grade dysplasia and early adenocarcinoma: a pathological study. Am J Gastroenterol 1997; 92: 586-591.
4. Clark GW, Ireland AP, Peters H, Chandrasoma P, DeMeester TR, Bremner CG. Short Segment Barrett's Esophagus: a prevalent complication of gastroesophageal reflux disease with malignant potential. J Gastrointest Surg 1997; 1: 113-122.
5. Csendes A, Smok G, Quiroz J et al. Clinical, endoscopic and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia Am J Gastroenterol 2002; 97: 554-560.
6. Mueller J, Werner M, Stolte M. Barrett's esophagus: histopathological definitions and criteria. World J Surg 2004; 28: 148-154.
7. Groisman GM, Amar M, Meir A. Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia. Mod Pathol 2004; 17: 1282-88.
8. Zaninotto G, Rizzetto C. Surgical options and outcomes in Barrett's esophagus Curr Opin Gastroenterol. 2007; 23: 452-5.
9. Jamieson JR, Stein HJ, DeMeester TR et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity and reproducibility. Am J Gastroenterol 1992; 87: 104-11.
10. Passaretti S, Zaninotto G, Di Martino N, Leo P, Costantini M, Baldi F. Standards for oesophageal manometry. A position statement from the Gruppo Italiano di Studio per la Motilita' dell'Apparato Digerente. Dig Liv Dis 2000; 32: 46-55.
11. Sampliner RE, Fennerty B., Garewal HS. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc. 1996; 44 532-5.
12. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of esophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-80.
13. Jass J, Filipe MN. A variant of intestinal metaplasia associated with gastric carcinoma. A histochemical study. Histopathology 1979; 3: 191-9.
14. Phillips RW, Frierson HF, Mosakuk A. Cdx2 as a marker of epithelial differentiation in the esophagus. Am J Surg Pathol 2003; 27: 1442 1447.
15. Rugge M, Correa P, Dixon MF, et al. Gastric dysplasia: the Padova International classification. Am J Surg Path 2000; 24: 167-76.
16. Kaur BS, Ouatu-lascar R, Omary MB et al. Bile salts induce or blunt cell proliferation in Barrett's esophagus in an acid-dependent fashion. Am J Physiol 2000; 278: G1000-9.
17. Ingravallo G, Dall'Olmo L, Segat D et al. Cdx2 Hox gene product in a rat model of esophageal cancer. J Experim & Clin Canc Res 2009; 29: 108-14.
18. Fassan M, Volinia S, Palatini J, et al. MicroRNA expression profiling in human Barrett's carcinogenesis. Int J Cancer. 2010 Dec 2. [Epub ahead of print].
19. Rugge M, Fassan M, Zaninotto G, et al Aurora kinase A in Barrett's carcinogenesis. Hum Pathol. 2010 Oct; 41(10): 1380-6. Epub 2010 Jul 24.
20. Bowers SP, Mattur SO, Smith CD, et al. Clinical and histologic follow-up after antireflux surgery for Barrett's esophagus. J Gastrointest Surg 2002; 6: 532-39.
21. Gurski RR, Peters JH, Hagenn JA et al Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive factors. J Am Coll Surg 2003; 196: 706-13.
22. Oelschager BK, Barreca M, Chang L, Oleynikov D, Pellegrini CA. Clinical and pathologic response of Barrett's esophagus after antireflux surgery. Ann Surg 2003; 238: 458-66.
23. O'Riordan JM, Byrne PJ, Ravi N, Keeling PW, Reynolds JV. Long-term clinical and pathologic response after antireflux surgery. Am J Surg 2004; 188: 27-33.
24. Zaninotto G, Cassaro M, Pennelli G, Battaglia G, et al. Barrett's epithelium after antireflux surgery. J Gastrointest Surg 2005; 9: 1253-1261.
25. Biertho L, Dallemagne B, Dewandre J-M et al. Laparoscopic treatment of Barrett's esophagus: long-term results. Surg Endosc 2007; 21: 11-5.
26. Csendes A, Braghetto I, Burdiles P et al. Late results of the surgical treatment of 125 patients with short-segment Barrett Esophagus. Arch Surg 2009; 144: 921-27.
27. Dikman R, Kim JL, Camargo L et al. Correlation of gastroesophageal reflux disease symptoms characteristics with long-segment Barrett's esophagus. Dis Esophagus 2006; 19: 360-5.
28. Zentilin P, Reglioni S, Savarino V. Pathophysiological characteristics of long- and short-segment Barrett's esophagus. Scand J Gastroenterol 2003; (S 38) 239: 40-43.
29. Zaninotto G, Portale G, Parenti A et al. Role of acid and bile reflux in development of specialized intestinal metaplasia in distal esophagus. Digest Liver Dis 2002; 34: 251-7.
30. Pfaffenbach B, Hullerum J, Orth et al. Bile and acid reflux in long and short segment Barrett's esophagus and in reflux disease. Z Gastroenterol 2000; 38: 565-70.
31. Horwhat JD, Baroni D, Maydonovitch C et al. Normalization of intestinal metaplasia in the esophagus and esophagogastric junction: incidence and clinical data Am J Gastroenterol 2007; 192: 497-506.
32. Souza RF, Krishnan K, Spechler J. Acid, bile and Cdx: the ABC of making Barrett's metaplasia. Am J Physiol Gastrointest Liver Physiol 2008; 295: 211-18.